Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideALNYAlnylam Pharmaceuticals
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Bullish
| Metric | ALNY | UNH |
|---|
| Close | 227.02 | 378.52 |
| Market Cap | $31.1B | $340B |
| 1M | −8.71% | −0.15% |
| P/E (TTM) | 38.5 | 24.1 |
| Forward P/E | 28.0 | 17.1 |
| P/E 5-Yr Percentile | — | 54 |
| P/S | 6.5 | 0.8 |
| P/B | 23.0 | 3.3 |
| Dividend Yield | — | 1.37% |
| Latest Quarter Revenue | $1.3B | $112B |
| Revenue YoY | +66.9% | +0.4% |
| Gross Margin | 76.9% | 88.1% |
| Latest Quarter EPS | 1.21 | 6.04 |
| Avg Post-Earnings Move | ±1.7% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.86% |
| 90-Day Net Insider Buying | −$0.40M | −$0.66M |
ALNY · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
